WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced the appointment of Adam Gridley to President and Chief Executive Officer and as a member of the Company’s Board of Directors. Mr. Gridley brings over 20 years of proven results in the medical device and pharmaceutical industries, with a combination of transactional and public markets experience as well as strong operational leadership and product development expertise. Mr. Gridley’s career has focused on strategic elements of corporate growth with a demonstrated and successful track record in strategic planning, manufacturing and R&D expansions, and corporate and technology integrations.
Help employers find you! Check out all the jobs and post your resume.
